On the “safe and effective” mantra we’re being fed by the government and media…

By nataliao on

They say “the vaccine is safe and effective”.

They say “it’s approved by FDA”.

But IS IT?

If that is indeed, then why we’re seeing so many clinical trials not only incomplete, but some are just starting out?

Why would one set up a clinical trial, mind you it costs a pretty penny to the company, to discover what they allegedly already know?

The answer is: THEY DO NOT KNOW. THEY HAVE NO IDEA HOW SAFE IT IS. THEY ARE RUNNING CLINICAL TRIALS IN PARALLEL WITH REAL-WORLD ROLLOUT. WE ARE IN THE CLINICAL TRIAL AND WE DID NOT CONSENT TO IT.

Let’s look at the source. https://clinicaltrials.gov

I’ve extracted a small subset of clinical trials from the website.

The estimated completion dates for these (except one) are in the future, which means the answer to the questions posed in the title are unknown.

(There are more completed and ongoing trials on clinicaltrials.gov)

TitleStart DateEstimated Completion Date# of participantsLocation
Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study – Kaiser PermanenteMay 15, 2021July 30, 2023999Southern California
COVID-19 Vaccine Boosters in Patients With CKD (BOOST KIDNEY)September 30, 2021September 30, 2023300Toronto, ON
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)June 4, 2021August 11, 2023240United States, Indiana
The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial DoseSeptember 8, 2021December 30, 2022100United States, Maryland
The Impact of Vaccination on Severity of Illness in COVID-19 That one is observational and it’s complete. See the results after this table.June 1, 2021June 7, 202111834 United States, Michigan
Beaumont Hospital – Royal Oak
Royal Oak, Michigan, United States, 48073
Immunocompromised Swiss Cohorts Based Trial Platform (COVERALL)April 19, 2021July 2022431Switzerland
COVID Protection After Transplant-Immunosuppression Reduction (CPAT-ISR)October 15, 2021March 2023400United States, across 7 states
SARS-CoV-2 Vaccination Strategies in Previously Hospitalized and Recovered COVID-19 PatientsAugust 25, 2021July 2022640United States, across 6 states + Spain

Here are the results of the one that’s completed (the one in BOLD above). It is observational and retrospective – they analyzed existing medical records, 11,834 of them. Note these are people who came to the hospital, not light infections or asymptomatic (formerly known as immune) people.

Measured OutcomeUnvaxxedPartially vaxxedFully vaxxed
Participants10880825129
Mean Age52.162.570.3
Number of Patients With Severe Infection733 (6.7%)85 (10.3%)16 (12.4%)
Number of Patients With ICU Admission619 (5.7%)75 (9.1%)14 (10.9%)
Number of Patients Requiring Mechanical Ventilation398 (3.7%)42 (5.1%)6 (4.7%)
Number of Patients With In-hospital Mortality384 (3.5%)50 (6.1%)8 (6.2%)

Notes:

  • Mean age of those fully vaxxed is almost 20 years higher than that of the other categories.
  • Fully vaxxed cohort is much smaller in comparison to the unvaxxed.
  • It is hard to adjust the conclusions for the difference in mean age of participants and the difference in the cohort size, but it is still shows that double jabs do not even bring the risk for elderly back to the unvaxxed risk.

More measured outcomes are available by following the link for this trial. I’ve just listed those that scream loud.

Does that look effective to you?

Leave a Reply